vs
BUCKLE INC（BKE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
BUCKLE INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.5倍（$320.8M vs $207.3M），BUCKLE INC净利率更高（15.2% vs -62.0%，领先77.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 9.3%），BUCKLE INC自由现金流更多（$38.4M vs $-100.8M）
Buckle Inc.是美国时尚零售企业，面向全年龄段消费者销售服饰、鞋履及配饰。目前在美国42个州运营451家门店，品牌包括Buckle和The Buckle，产品涵盖知名品牌及自有品牌服饰，含牛仔装、休闲下装、上衣、连衣裙、运动休闲服饰、外套、鞋类、泳装、香氛及箱包配饰等。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
BKE vs RARE — 直观对比
营收规模更大
BKE
是对方的1.5倍
$207.3M
营收增速更快
RARE
高出16.6%
9.3%
净利率更高
BKE
高出77.2%
-62.0%
自由现金流更多
BKE
多$139.2M
$-100.8M
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $320.8M | $207.3M |
| 净利润 | $48.7M | $-128.6M |
| 毛利率 | 48.0% | — |
| 营业利润率 | 19.0% | -54.7% |
| 净利率 | 15.2% | -62.0% |
| 营收同比 | 9.3% | 25.9% |
| 净利润同比 | 10.3% | 3.5% |
| 每股收益（稀释后） | $0.96 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKERARE
| Q4 25 | $320.8M | $207.3M | ||
| Q3 25 | $305.7M | $159.9M | ||
| Q2 25 | $272.1M | $166.5M | ||
| Q1 25 | $379.2M | $139.3M | ||
| Q4 24 | — | $164.6M | ||
| Q3 24 | — | $139.5M | ||
| Q2 24 | — | $147.0M | ||
| Q1 24 | — | $108.8M |
净利润BKERARE
| Q4 25 | $48.7M | $-128.6M | ||
| Q3 25 | $45.0M | $-180.4M | ||
| Q2 25 | $35.2M | $-115.0M | ||
| Q1 25 | $77.2M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | — | $-133.5M | ||
| Q2 24 | — | $-131.6M | ||
| Q1 24 | — | $-170.7M |
毛利率BKERARE
| Q4 25 | 48.0% | — | ||
| Q3 25 | 47.4% | — | ||
| Q2 25 | 46.7% | — | ||
| Q1 25 | 52.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率BKERARE
| Q4 25 | 19.0% | -54.7% | ||
| Q3 25 | 18.4% | -106.9% | ||
| Q2 25 | 16.0% | -64.8% | ||
| Q1 25 | 25.4% | -102.6% | ||
| Q4 24 | — | -74.3% | ||
| Q3 24 | — | -94.6% | ||
| Q2 24 | — | -79.1% | ||
| Q1 24 | — | -151.9% |
净利率BKERARE
| Q4 25 | 15.2% | -62.0% | ||
| Q3 25 | 14.7% | -112.8% | ||
| Q2 25 | 12.9% | -69.0% | ||
| Q1 25 | 20.4% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | — | -95.7% | ||
| Q2 24 | — | -89.5% | ||
| Q1 24 | — | -156.8% |
每股收益（稀释后）BKERARE
| Q4 25 | $0.96 | $-1.28 | ||
| Q3 25 | $0.89 | $-1.81 | ||
| Q2 25 | $0.70 | $-1.17 | ||
| Q1 25 | $1.54 | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | — | $-1.40 | ||
| Q2 24 | — | $-1.52 | ||
| Q1 24 | — | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.0M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $510.7M | $-80.0M |
| 总资产 | $1.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BKERARE
| Q4 25 | $24.0M | $421.0M | ||
| Q3 25 | $22.1M | $202.5M | ||
| Q2 25 | $22.9M | $176.3M | ||
| Q1 25 | $23.8M | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M | ||
| Q1 24 | — | $112.3M |
股东权益BKERARE
| Q4 25 | $510.7M | $-80.0M | ||
| Q3 25 | $476.2M | $9.2M | ||
| Q2 25 | $445.3M | $151.3M | ||
| Q1 25 | $423.8M | $144.2M | ||
| Q4 24 | — | $255.0M | ||
| Q3 24 | — | $346.8M | ||
| Q2 24 | — | $432.4M | ||
| Q1 24 | — | $140.3M |
总资产BKERARE
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $977.3M | $1.3B | ||
| Q1 25 | $913.2M | $1.3B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | — | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $-100.8M |
| 自由现金流率自由现金流/营收 | 12.0% | -48.6% |
| 资本支出强度资本支出/营收 | 3.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.02× | — |
| 过去12个月自由现金流最近4个季度 | $215.3M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流BKERARE
| Q4 25 | $49.4M | $-99.8M | ||
| Q3 25 | $58.4M | $-91.4M | ||
| Q2 25 | $31.0M | $-108.3M | ||
| Q1 25 | $120.8M | $-166.5M | ||
| Q4 24 | — | $-79.3M | ||
| Q3 24 | — | $-67.0M | ||
| Q2 24 | — | $-77.0M | ||
| Q1 24 | — | $-190.7M |
自由现金流BKERARE
| Q4 25 | $38.4M | $-100.8M | ||
| Q3 25 | $46.4M | $-92.7M | ||
| Q2 25 | $19.6M | $-110.7M | ||
| Q1 25 | $111.0M | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率BKERARE
| Q4 25 | 12.0% | -48.6% | ||
| Q3 25 | 15.2% | -58.0% | ||
| Q2 25 | 7.2% | -66.5% | ||
| Q1 25 | 29.3% | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度BKERARE
| Q4 25 | 3.4% | 0.5% | ||
| Q3 25 | 3.9% | 0.8% | ||
| Q2 25 | 4.2% | 1.5% | ||
| Q1 25 | 2.6% | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
现金转化率BKERARE
| Q4 25 | 1.02× | — | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BKE
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
